Venture capital investment vehicle Primo Capital has announced that it has completed a new exit, selling its majority stake in Lambda to R\u00f6ko, which has acquired 85% of the company, while the remaining 15% will continue to be held by Lambda’s management team. R\u00f6ko is a Swedish organisation specialising in the acquisition and management of high-potential small and medium-sized enterprises. <\/p>\n\n
The transaction represents an important step for Primo Capital and confirms the asset management company’s ability to accompany high-potential technology companies throughout their growth phases, through targeted strategic and operational support.<\/p>\n\n
Founded in Italy, Lambda is a portfolio company of Health, one of the leading healthcare venture capital funds currently managed by Primo Capital and supported by major institutional investors such as Fondazione ENPAM. The company designs and manufactures erbium and diode laser systems for dental, veterinary and artistic restoration applications, marketed under the Doctor Smile, Doctor Vet and Doctor Art brands. The company serves customers in over 30 countries, thanks to a team of more than 40 employees. <\/p>\n\n
The acquisition of the stake in Lambda represents a fundamental step in the consolidation of R\u00f6ko’s B2B business.<\/p>\n\n
Antonio Concolino, CEO of Primo Capital, (pictured) said in a statement: “This transaction confirms our strong commitment to creating value for our investors, while supporting our portfolio companies in accessing the best growth opportunities. Lambda marks our first exit of 2026, following a 2025 that saw three further exits in sectors that are fundamental to Italian and European competitiveness and resilience, such as data privacy with Keyless Technologies, applied artificial intelligence with Competitoor, and cybersecurity with Muscope Cybersecurity.”<\/p>\n\n
The value of the transaction was not disclosed. <\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Venture capital scores its first exit of 2026 by selling the medical device manufacturer<\/p>\n","protected":false},"author":125,"featured_media":149557,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1142],"tags":[1486,1137,1136,1145],"companies":[2579],"journalist":[1518],"class_list":["post-149626","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vc-voice","tag-exit-en","tag-italy-en","tag-startup-en-2","tag-venture-capital-en-2","companies-primo-capital-en","journalist-editorial-staff-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/02\/concolino-piccola.webp","width":150,"height":150,"crop":false,"srcset":false,"alt":"exit primo capital"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/02\/concolino-piccola.webp","width":1022,"height":1024,"crop":false,"srcset":false,"alt":"exit primo capital"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/02\/concolino-piccola.webp","width":1108,"height":1110,"crop":false,"srcset":false,"alt":"exit primo capital"}},"acf":[],"yoast_head":"\n